Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
pRb2/p130 is a key tumor suppressor, whose oncosuppressive activity has mainly been attributed to its ability to negatively regulate cell cycle by interacting with the E2F4 and E2F5 transcription factors.
|
25205458 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The RB (pRb2/p16) and p53 (p14/p53/p21) tumor-suppressor pathways in endemic Burkitt lymphoma.
|
21127431 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our results support the hypothesis that platelet GP Ib-IX functions that support normal hemostasis or pathologic thrombosis also contribute to tumor malignancy.
|
17494758 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy.
|
17708530 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The retinoblastoma family members--pRb, pRb2/p130 and p107--are tumor suppressor genes involved in controlling four major cellular processes: growth arrest, apoptosis, differentiation and angiogenesis.
|
16936751 |
2006 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
A careful analysis of pRb2/p130 expression in tumor specimens could help to identify the best clinical protocol to be used for each patient, improving efficacy and tolerance and therefore offering additional progress in the treatment of advanced ovarian cancer.
|
15585644 |
2004 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Immunohistochemical analysis revealed loss or decrease of pRb2/p130 expression in 18 cases (40%). pRb2/p130 expression was mostly nuclear and inversely correlated to the tumor grade (P < 0.05).
|
15131049 |
2004 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The survival rate of patients with esophageal SCCs expressing pRb2/p130 was significantly better than that of patients with tumors without pRb2/p130 expression (P= 0.016).
|
12474056 |
2002 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We found no mutations in the RB2/p130 gene and unusually high percentages of cells expressing nuclear pRb2/p130 in tumors with a high proliferative activity, such as AIDS-related lymphomas.
|
12196924 |
2002 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Among the three family members, the retinoblastoma-related gene product pRb2/p130 is a tumor suppressor gene and an effective candidate target for gene therapy approach.
|
11029489 |
2000 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In patients with endometrial carcinoma who did not receive radiotherapy or chemotherapy before surgery, the presence of decreased levels of pRb2/p130 in tumor cells is associated with a significantly increased risk of recurrence and death of disease, independent of tumor stage and ploidy status.
|
9508194 |
1998 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumor cells were injected subcutaneously into nude mice, and tumor growth, with or without induced expression of pRb2/p130, was monitored.
|
9776410 |
1998 |